Evidence map›Paper›PMID 36865896›Full record

ArticleGlobal health & medicine2023

Trends in surgical treatment for prostate cancer: Analysis of National Database Open Data in Japan.

Masaki Nakamura, Motofumi Suzuki, Taro Izumi, Ibuki Tsuru, Yasuko Muraki, Haruki Kume

Abstract read
In one paragraph

Article in Global health & medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masaki NakamuraDepartment of Urology, NTT Medical Center Tokyo, Tokyo, Japan.
Motofumi SuzukiDepartment of Urology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Taro IzumiDepartment of Urology, NTT Medical Center Tokyo, Tokyo, Japan.
Ibuki TsuruDepartment of Urology, NTT Medical Center Tokyo, Tokyo, Japan.
Yasuko MurakiNursing Department, NTT Medical Center Tokyo, Tokyo, Japan.
Haruki KumeDepartment of Urology, The University of Tokyo Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a study to clarify the trends in surgical treatments for prostate cancer in Japan between 2014 and 2020 by analyzing the National Database (NDB) Open Data in Japan. Intriguingly, the number of patients over 70 years old who underwent robotic-assisted radical prostatectomy (RARP) nearly doubled from 2015 to 2019, while that in those 69 years old and younger remained almost constant during the same period. The increase in the number of patients over 70 years of age may reflect the fact that RARP can be safely applied to elderly patients. With the new development and spread of surgery-assisting robots, we can foresee a further increase in the number of RARPs performed for elderly patients in the future.

Indexed as

COVID-19NDB Open Datarobotic-assisted radical prostatectomy

Identifiers

PMID36865896
PMCPMC9974222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.